2024 Annual Meeting | H17 - Operationalizing Advanced Drug Services from Screening to Infusion (Practice and Policy Hub)

Date Saturday 04/13/24

Time 01:00 PM - 02:00 PM MDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Hubs (Practice and Policy)

Director(s) Katherine Coerver, MD, PhD, FAAN, Amy R. Knighton, CPC, FACMPE, Marcelo Matiello, MD, FAAN

Topic(s) Practice, Policy, and Ethics

Learning Objectives Participants should gain an understanding of the challenges posed by cognitive screening in the context of limited neurologist resources and breakthrough drug interventions; learn from experts about collaborative multi-disciplinary team models and value-based care approaches to optimize cognitive screening and intervention; discover cutting-edge automated screening tools spanning population-based, community-based, and web-based approaches to extend cognitive screening reach; and gain insights into identifying and mitigating care disparities within the aging population through equitable access to cognitive screening and interventions.

CME Available 1.00 CME credit

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement

Program Level Introductory

Program Tracks Diversity, Equity, and Inclusion

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator

Teaching Styles Case-based, Audience Participation

Program Evaluations

Event Timeline
01:00 PM - 01:15 PM MDT	Speaker	Cognitive Screening Challenges and Drug Breakthroughs Katherine Coerver, MD, PhD, FAAN
01:15 PM - 01:30 PM MDT	Speaker	Multi-Disciplinary Team-based Care Amy R. Knighton, CPC, FACMPE
01:30 PM - 01:45 PM MDT	Speaker	Efficient Screening Tools for the Aging Population Marcelo Matiello, MD, FAAN
01:45 PM - 02:00 PM MDT	Discussion	Shaping the Future of Brain Health Screening and Care Katherine Coerver, MD, PhD, FAAN, Amy R. Knighton, CPC, FACMPE, Marcelo Matiello, MD, FAAN

Faculty Disclosures
Katherine Coerver, MD, PhD, FAAN	Dr. Coerver has received personal compensation for serving as an employee of CenExel. Dr. Coerver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai . Dr. Coerver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ZS Associates. Dr. Coerver has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai . Dr. Coerver has received research support from Lilly. Dr. Coerver has received research support from Annovis. Dr. Coerver has received research support from Biogen. Dr. Coerver has received research support from AriBio. Dr. Coerver has received research support from Actinogen.
Lidia Maria V. Moura, MD, PhD, MPH, FAAN	The institution of Dr. Moura has received research support from Centers for Diseases Control and Prevention (CDC SIP20-007) . The institution of Dr. Moura has received research support from Epilepsy Foundation of America . The institution of Dr. Moura has received research support from NIH - NIA and NINDS. Dr. Moura has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with Epilepsy Foundation .
Amy R. Knighton, CPC, FACMPE	Mrs. Knighton has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merz. Mrs. Knighton has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Mrs. Knighton has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics.
Marcelo Matiello, MD, FAAN	Dr. Matiello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Matiello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.

��ɫ��

��ɫ��